Trials / Not Yet Recruiting
Not Yet RecruitingNCT06577077
Efficacy/ Safety of Product CM9241GRU in Patients With Perennial Allergic Rhinitis
Randomized Clinical Trial to Evaluate the Efficacy and Safety of Product CM9241GRU in Relieving Nasal Symptoms in Perennial Allergic Rhinitis
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 432 (estimated)
- Sponsor
- Ache Laboratorios Farmaceuticos S.A. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and safety of CM9241GRU versus placebo in the treatment of perennial allergic rhinitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Product CM9241GRU | 01 tablet in the morning and 01 tablet in the evening for 14 days |
| DRUG | Placebo | 01 tablet in the morning and 01 tablet in the evening for 14 days |
Timeline
- Start date
- 2024-09-01
- Primary completion
- 2025-08-01
- Completion
- 2025-08-01
- First posted
- 2024-08-29
- Last updated
- 2024-08-29
Source: ClinicalTrials.gov record NCT06577077. Inclusion in this directory is not an endorsement.